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Background: The vitamin D3 receptor (VDR) is responsible for mediating the pleiotropic and, in part,
cell-type-specific effects of 1,25-dihydroxyvitamin D3 (calcitriol) on the cardiovascular and the muscle system,
on the bone development and maintenance, mineral homeostasis, cell proliferation, cell differentiation,
vitamin D metabolism, and immune response modulation.
Results: Based on data obtained from genome-wide yeast two-hybrid screenings, domain mapping studies,
intracellular co-localization approaches as well as reporter transcription assay measurements, we show here that
the C-terminus of human PIM-1 kinase isoform2 (amino acid residues 135–313), a serine/threonine kinase of the
calcium/calmodulin-regulated kinase family, directly interacts with VDR through the receptor’s DNA-binding
domain. We further demonstrate that PIM-1 modulates calcitriol signaling in HaCaT keratinocytes by
enhancing both endogenous calcitriol response gene transcription (osteopontin) and an extrachromosomal DR3
reporter response.
Conclusion: These results, taken together with previous reports of involvement of kinase pathways in VDR
transactivation, underscore the biological relevance of this novel protein-protein interaction.
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Vitamin D receptorBackground
Genomic control of primary calcitriol-responsive genes
is primarily achieved by binding of (phosphorylated)
vitamin D receptor (VDR)-retinoid X receptor (RXR)
heterodimers in a non-symmetrical head to tail arrange-
ment to vitamin D response elements (VDRE) located
within the promotor regions of target genes [1]. Core-
pressor proteins such as hairless, Alien, NCoR (nuclear
receptor corepressor) or SMRT (silencing mediator for
retinoic acid receptor and thyroid hormone receptor)
link non-liganded DNA-bound VDR or antagonist-
destabilized nuclear hormone receptor (NHR)-coactiva-* Correspondence: k.oender@salk.at
†Equal contributors
1Division of Molecular Dermatology, Department of Dermatology, Paracelsus
Medical University, Salzburg, Austria
Full list of author information is available at the end of the article
© 2012 Maier et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the ortor complexes to enzymes with histone deacetylase
(HDAC) activity and as a result promote condensation
of chromatin to repress basal transcription [2,3]. The
binding of calcitriol or one of its agonists triggers the re-
lease of corepressors, accompanied by subsequent re-
cruitment of coactivators of the p160 family and finally
of more general cofactors such as CBP/p300 to mediate
local chromatin remodeling and stable assembly of the
basal transcriptional machinery [1]. Secondly, calcitriol
can also mediate ‘rapid responses’ that are elicited by
still debatable receptor(s) located near or associated with
the plasma membrane and its caveolae compartments
[4]. These effects occur within minutes after hormone
administration, are too rapid to involve changes in gene
expression but instead direct an increase in numerous
second messengers that can, though, ultimately affect
transcription through secondary cross-talk with other
(kinase) signal transduction cascades [5,6].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Maier et al. BMC Molecular Biology 2012, 13:18 Page 2 of 13
http://www.biomedcentral.com/1471-2199/13/18Despite an already substantial quantity of literature on
VDR biology - for example, 1α,25- dihydroxyvitamin D3
signaling; classification of agonistic/antagonistic VDR
ligands synthesized with the goal to improve the bio-
logical profile of the natural hormone for therapeutic ap-
plication; descriptions of associations between VDR and
a variety of interactors as listed in the Primos (http://pri-
mos.fh-hagenberg.at) and Biogrid (http://www.thebio-
grid.org) database; as well as descriptions of structural
motifs and conformational changes responsible for tran-
scriptional control - there remain important regulatory
aspects and mechanisms that have not been comprehen-
sively elucidated.
By performing a genome-wide yeast two-hybrid (Y2H)
screen using human VDR as bait in order to detect new
protein-protein interactions (PPIs) to obtain a more
complete understanding of the mode of action of VDR,
we were able to identify a previously unknown binding
partner, PIM-1 (NCBI accession no. NM_002648). PIM-
1 (proviral insertion of Moloney murine leukemia virus),
which is a serine/threonine kinase of the calcium/
calmodulin-regulated kinase (CAMK) family, phosphory-
lates different downstream effectors and has accordingly
been proposed to play a key role in cell-cycle progression,
cell survival, and differentiation of a variety of cell types
[7-10]. Here we identify PIM-1 kinase as a novel VDR
interacting protein whose overexpression significantly
enhances and knock-down suppresses both, endogenous
calcitriol response gene transcription (osteopontin) and
an extrachromosomal DR3 (direct repeat of 2 hexamers
spaced by 3 nucleotides) reporter response. These find-
ings suggest involvement of the VDR-PIM-1 interaction
in calcitriol-mediated growth and especially differenti-
ation of keratinocytes.Figure 1 Illustration of the used VDR/Pim-1 variants. (A) In addition to
Ligand Binding Domain (LBD: AA 111–427) of the VDR were subjected for
PIM-1 isoform 2 as well as the truncated version of PIM-1 (AA 135–313).Results
Genome-wide screening of a human cDNA library for VDR
interacting proteins delivered PIM-1 kinase as candidate
interactor
To identify novel interactors of human VDR we carried
out a Y2H assay by screening full length human VDR
against a bone marrow cDNA library contained in the
pAD-Gate1 to 3 vector system, as described by Maier
et al. [11]. From approximately 5 × 106 yeast transfor-
mants we recovered a total of 43 different positive clones
expressing putative VDR interactors. We concentrated
our efforts on one clone encoding a carboxy-terminal
fragment of PIM-1 kinase [amino acids (AA) 135–313],
as determined via homology searches using NCBI
BLAST. However, prior to further experimentation we
first demonstrated the existence of PIM-1 mRNA in
HaCaT keratinocytes by using gene-specific real-time
PCR primers (data not shown); this positive result indi-
cated that our newly identified protein-protein inter-
action could plausibly take place not only in human
bone-marrow but also in human skin cells.
The VDR DNA-binding domain is a PIM-1 interaction site
We isolated full-length human PIM-1 kinase from the
cDNA library using gateway-compatible oligonucleotides
and then subcloned the cDNA into pAD-Gate2 via
standard BP-/LR-reactions. Now, using the full-length
PIM-1 clone, we repeated the Y2H test against VDR and
confirmed the positive interaction. To determine the
VDR regions potentially involved in PIM-1 binding, we
subcloned the VDR fragment encoding the DNA-binding
domain and the fragment encoding the ligand-binding
domain (LBD) separately into the vector pBD-Gate2
for Y2H screening against full-length PIM-1 as well asfull-length VDR the DNA Binding Domain (DBD: AA 16–125) and the
Y2H analysis as bait molecules. They were tested with (B) full-length
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(Figure 1). Yeast cells co-transformed with the VDR LBD
and either full-length PIM-1 isoform 2 or truncated
PIM-1 (AA 135–312) failed to grow on SD/-trp-leu-ade-
his medium, whereas cells expressing both the VDR
DNA-binding domain and PIM-1 kinase did grow
(Figure 2). This result indicates that the PIM-1 binding
site of VDR maps to the fragment encoding the VDR
DNA-binding domain.
In silico examination of human PIM-1 kinase revealed
the presence of a putative nuclear hormone receptor cor-
egularoty LxxLL motif, namely L228-G-I-L231-L232 (albeit
not in a conserved context), within the minimal VDR
interaction domain. The general trend for LxxLL motifs
(where L is leucine and x is any amino acid) that mediate
the association between cofactors and liganded nuclear
hormone receptors to modulate transcription includes a
hydrophobic residue positioned at −1 and −7, a proline
residue at −2, an aromatic residue at −3 and glutamate atFigure 2 Domain analysis of PIM-1 – VDR interaction. (A) Yeast
cells co-transformed with PIM-1-pAD-Gate2 and VDR-Fullength-pBD
-Gate2 grow directly on PPI selective medium as well as yeast cells
co-transformed with PIM-1-pAD-Gate2 and DBD-pBD-Gate2. Cells
co-transformed with PIM-1-pAD-Gate2 and LBD-pBD-Gate2,
PIM-1-pAD-Gate2 and pBD-Gate2, pAD-Gate2 and
VDR-Fullength-pBD-Gate2, pAD-Gate2 and DBD-pBD-Gate2, or
pAD-Gate2 and LBD-pBD-Gate2 show no growth on PPI selective
medium. (B) All combination show strong growth on medium
selective for positive transformation.location −5 to create an L-x-E/H-x-H/F-P-L/M/I-L-x-x-
L-L consensus pattern [12]; however, the PIM-1 se-
quence in this stretch is R-S-A-A-V-W-S-L228-G-I-L231-
L232. Although the AA residues flanking the LxxLL main
core motif are known to be important for the recognition
of selected classes of nuclear hormone receptors, the
exact number and composition of LxxLL motifs can vary
considerably among different coactivators [13].
PIM-1 kinase and VDR colocalize in the nucleus of HaCaT
keratinocytes
Mammalian expression constructs for YFP-VDR and red
fluorescent PIM-1 were used to transfect cultured
HaCaT keratinocytes to visualize the subcellular
localization of VDR and PIM-1, and to evaluate the in-
fluence of 200 nM calcitriol (or ethanol as vehicle) on
this distribution. YFP-tagged VDR was observed to be
predominantly located in the nucleus independent of
calcitriol treatment and residually in the cytoplasm. This
result differs from previous studies, which reported that
unliganded VDR partitions consistently between the
cytoplasm and the nucleus, as observed in a variety of
cell types such as COS-7 cells deficient in expressing
endogenous VDR, CV-1 fibroblasts, rat ROS17/2.8
osteosarcoma cells, mouse adenocarcinoma cells, 293
adenovirus-transformed human embryonal kidney cells,
and human dermal fibroblasts, and undergoes substantial
translocation into the nucleus upon calcitriol treatment
[14]. Real-time PCR experiments analyzing expression of
CYP24A1 or OPN, which are well known VDR-target
genes as well as Western blots of lysates of untransfected
HaCaT cells in comparison to YFP-VDR-overexpressing
samples (data not shown) have in this context confirmed
that the tagged nuclear hormone receptor is fully
functional.
PIM-1 kinase also was observed to be predominantly
nuclear, however, not throughout the complete nucleus.
A dense concentration of PIM-1 in an undefined local
nuclear region (not corresponding to the nucleolus) was
observed, where it patially colocalizes with VDR in
HaCaT keratinocytes (Figure 3). A residual cytoplasmic
staining was also observed. Its intracellular distribution
was not obviously influenced by the presence or absence
of calcitriol (data not shown). Previous studies have
described both cytoplasmic and especially nuclear PIM-1
localization, as visualized via biochemical cell fraction-
ation studies [15], transfection of a GFP-tagged PIM-1
kinase into HeLa cells [16], or anti-PIM-1 antibody
staining approaches [17]; in the latter study the kinase
was detected in both the cytoplasm and nucleus at an
early stage of U937 PMA (phorbol myristate acetate)-
induced cell differentiation but then underwent a dra-
matic shift toward the nucleus after 24 h of exposure to
this substance.
Figure 3 PIM-1 and VDR co-localization in human keratinocytes. HaCaT cells were co-transfected with PIM-1-DsRed and VDR-YFP fusion
constructs. (A) Image of the YFP-fluorescence of VDR. (B) Image of the red fluorescence of PIM-1. (C) Image of blue DAPI fluorescence.
(D) Overlay of panels A, B and C showing colocalization of PIM-1 and VDR in the nucleus.
Figure 4 Real-Time analysis of PIM-1 trancription in human
keratinocytes upon calcitriol stimulation. HaCAT cells were
induced either with 0.2 μM calcitriol or with an equal amount of
ethanol for 16 h. Levels of gene expression were analyzed by
Real-Time PCR, and are shown as fold change differences between
vehicle and calcitriol induction relative to the housekeeping gene
ANXA1. The expression levels of PIM-1 show no significant
differences between calcitriol and ethanol induction (p-value = 0,5),
whereas CYP24A1 gene expression shows an enormous increase
with calcitriol induction (p-value = 0.0002). Error bars represent the
standard error of the mean (SEM) of n = 3 values.
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To further evaluate the behaviour of PIM-1 kinase upon
the treatment with calcitriol, total RNA extracted from
cultured HaCaT keratinocytes as well as 293HEK (human
embryonic kidney) cells that had been exposed to 200 nM
calcitriol (or an equal amount of ethanol) for 16 h was re-
verse transcribed into cDNA and subjected to real-time
PCR analysis. The RNA expression levels were observed
with gene-specific primers chosen according to the pub-
lished sequences of human PIM-1, CYP24A1 (encoding
25-hydroxyvitamin D24-hydroxylase or 24-OHase), a typ-
ical positive control target gene whose perceived upregu-
lations were in accordance to recent publications [18],
and ANXA1 as internal reference gene. Melting curve
examinations, agarose gel electrophoresis and DNA-
sequencing determined that the amplified products were
indeed specific; in addition, a negative control for each
RNA specimen was prepared. Following normalization,
calcitriol induction in both cell types was evident, but no
difference in the mRNA levels of PIM-1 kinase could be
observed, suggesting that PIM-1 kinase is not a calcitriol
target gene (Figure 4).
PIM-1 overexpression enhances mRNA transcription of
VDR-target genes and activates response of
extrachromosomal VDR-reporter constructs
calcitriol independently
In a further real-time PCR experiment, we analyzed the
effect of overexpression of PIM-1 kinase on osteopontin
(OPN) and CYP24A1 (CYP24) mRNA levels in the ab-
sence of calcitriol treatment; the expression level of
ANXA1 was used as an internal control. The results, pre-
sented in Figure 5, clearly show that both OPN and
CYP24 mRNA levels are increased by PIM-1 overexpres-
sion (36- and 4-fold, respectively), suggesting that PIM-1kinase overexpression provokes an calcitriol-independent
enhancement of OPN and CYP24 transcription mediated
by VDR. Because it is conceivable that the endogenous
activation of transcription we observed is mediated
through epigenetic mechanisms, we also tested a com-
mercially available extrachromosomal DR3 reporter con-
struct designed for accurate, sensitive and quantitative
assessment of the activation of signal transduction path-
ways, bears no other interaction sites for additional
Figure 5 Endogenous VDR target gene mRNA expression in PIM-1 overexpressing human keratinocytes. With PIM-1 overexpression the
levels of CYP24A1, PIM-1, and OPN are increased after normalization with the housekeeping gene ANXA1. Results are shown as fold change of
PIM-1 overexpression relative to cells transfected with the empty vector. The significant differences of PIM-1 overexpression compared to the
empty control vector samples was considered as true by the low p-values. Error bars represent the SEM of n = 3 values.
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stimulation through VDR binding takes place. For this
purpose we co-transfected PIM-1 kinase construct with
an equal amount of a VDRE-luc reporter construct into
HaCaT cells, treated half of the samples with calcitriol
and then performed a Dual-LuciferaseW Reporter Assay
in which we detected firefly as well as Renilla luciferase
signals with a luminometer. Following normalization of
the obtained firefly values by the recorded Renilla signals,
we observed a greatly increased calcitriol-stimulated luci-
ferase signal of about 2.8-fold in PIM-1-overexpressing
samples compared to cells transfected with an empty ex-
pression vector (Figure 6A). Because the cells treated
with ethanol showed the same enhancement in the luci-
ferase signal compared to calcitriol induction, we con-
clude from these studies that overexpression of PIM-1 in
HaCaT cells is able to enhance both the calcitriol-
independent and calcitriol-dependent extrachromosomal
DR3 reporter response.
PIM-1 dependence of VDR mediated transcriptional
response was shown by knockdown of
endogenous PIM-1
To show PIM-1 dependence of VDR-promoter binding
and response gene activation, we knocked down PIM-1
expression by RNAi and analysed transcriptional activa-
tion of extrachromosomal DR3 reporter construct.
Therefore PIM-1 specific short hairpin RNA (shRNA) en-
coding plasmids were co-transfected with an equal
amount of a VDRE-luc reporter construct into HaCaT
cells. The transfected cells were treated half with calcitrioland then a Dual-LuciferaseW Reporter Assay was per-
formed. The knockdown of endogenous PIM-1 results in
a reduced calcitriol-stimulated luciferase signal to the half
compared to the control transfection (Figure 6B). The
fact that in calcitriol-independent signalling the shRNA
construct against PIM-1 shows about the same reduction
compared to the negative control support the theory that
PIM-1 is able to enhance extrachromosomal DR3 re-
porter response independ of calcitriol.
PIM-1 kinase was found to take part in the
VDR-interacting protein complex of human cells
To verify the interaction between PIM-1 and VDR a
pull-down of DRIP (VDR interacting protein) complex
from cell lysates was performed.
Therefore a human keratinocyte lysate was prepared
and incubated with a biotinylated synthetic VDR specific
LXXLL nuclear receptor binding motif peptide, DRIP2
[19]. The biotinylated DRIP-2 peptide was immobilized
using magnetic streptavidin beads. The VDR complex
from human keratinocytes was captured by the immobi-
lized DRIP-2 peptide (Figure 7). As a control for unspe-
cific binding a lysate without DRIP-2 was incubated with
the beads. The resulting eluates were analyzed by west-
ern blotting with an anti-VDR and an anti-PIM1-
antibody (Figure 7).
VDR as well as PIM-1 isoform 2 could be detected in
the VDR-protein complex from human keratinocyte cell
lysates captured by the DRIP-2 peptide. Furthermore, an
unspecific protein band appeared which is about the size
of an putative VDR/PIM-1 complex (Figure 7). Despite
Figure 6 PIM-1 dependent VDR-transactivation. (A) PIM-1 overexpression enhances calcitriol-induced extrachromosomal DR3 reporter
response. The luminescence signal increased after induction of the transfected HaCaT cells with 0.2 μM calcitriol for 16 h but not following the
addition of an equal amount of ethanol for the same time. The cells transfected with PIM-1 showed a 2.8-fold increase in response to
calcitriol compared with the cells transfected with empty vector (pDEST26/neg control). Also, similar signal intensities were observed for
vehicle-treated cells transfected with PIM-1 vs. vehicle-treated cells transfected with the empty vector. (B) PIM-1 knockdown through shRNA
plasmid constructs reduces the calcitriol-induced extrachromosomal DR3 reporter response to the half compared with the cells transfected with
the neg. control shRNA plasmid. Furthermore, about the similar decrease was observed by calcitriol-independent extrachromosomal DR3 reporter
response. Vehicle-treated cells transfected with shRNA against PIM-1 vs. vehicle-treated cells transfected with the empty vector (pGFP-V-RS/neg.
control) reduces the signal intensity. Error bars represent the SEM of n = 3 values.
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and western blot analysis there is still the possibility of
an remaining VDR/PIM-1 complex which would be a
further evidence for real interaction. In the control nei-
ther VDR nor PIM-1 was detected.Discussion
The present study reports a previously unknown
protein-protein interaction between human VDR and
PIM-1 kinase and an involvement of a futher kinase in
calcitriol signaling. VDR is an evolutionarily conserved
Figure 7 Isolation of VDR-protein complex from human keratinocyte cell lysate. (A) Overview of the experimental procedure of the
pull-down assay. (B) Western blot analysis with anti-PIM1 and anti-VDR antibody. PIM-1 and VDR were observed only in the lysate captured by
the DRIP-2 peptide, while in the control lysate without peptide only unspecific lanes appeared. The expected sizes were for VDR about 48 kD,
for PIM-1 about 34 kD and for the putative VDR/PIM-1 complex (unspecific band) respectively about 82 kD.
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expressed in malignant specimens (e.g. carcinomas and
melanomas) and numerous mammalian tissues and,
most crucially for our study, in bone and skin where it
can be detected in a variety of cell types, including kera-
tinocytes, fibroblasts, Langerhans cells, melanocytes,
endothelial cells, and B- and T-lymphocytes [20,21].
PIM-1, originally identified as a locus frequently acti-
vated by proviral insertion of the Moloney murine
leukemia virus [22], encodes a highly conserved 313 AA
serine/threonine kinase of the calcium/calmodulin-regu-
lated kinase (CAMK) family whose expression is stimu-
lated by a variety of cytokines, hormones and mitogens.
PIM-1 appears to be involved in the control of cell
growth, differentiation, apoptosis and malignant trans-
formation [9,15,17,23]. Putative PIM-1 kinase substrates
and interactors include the c-Myb transcription factor
nuclear adapter protein p100 [24], the G1-specific cell-
cycle regulator Cdc25A [25], HP1 [26], the cdk inhibitor
p21cip1/waf1 [27], the nuclear mitotic apparatus protein
NuMA [28] and the proapoptotic protein Bad [29], which
are to a large extent involved in regulating cell-cycle pro-
gression and apoptosis. Nevertheless, the altogether small
number of reported substrates would seem unlikely to be
able to account for the broad spectrum of PIM-1 kinase
functions, implying that it most probably interacts withadditional, to date unidentified cellular substrates in spe-
cific physiological environments.
Expression of PIM-1 occurs in a wide range of tissues:
hematopoietic and lymphoid tissue, prostate, testis,
ovary, small intestine, colon, hippocampus and oral epi-
thelia. It is significantly upregulated in B-cell lymphomas
and erythroleukemias and has, via multi-tissue Northern
blotting, been detected in a number of squamous cell
carcinoma-derived keratinocyte lines, and in early and
late passages of both spontaneously immortalized kerati-
nocytes and normal human epidermal cells where its ex-
pression was substantially higher after confluence than
during the logarithmic growth phase and correlated with
increased keratinocyte differentiation [30-34]. There is
an obvious overlap in the expression of VDR and PIM-1
kinase in a variety of calcitriol-responsive tissues.
Support for the biological significance of our discovery
of a physical interaction between human VDR and PIM-
1 kinase is the fact that most nuclear hormone receptors
are phosphoproteins [extensively studied examples are
ERα [35], PR [36], and mouse RARα [37]], whereby
phosphorylation status can apparently govern receptor
activity under the prevailing cellular conditions. Human
VDR has been shown to be phosphorylated by protein
kinase C (PKC) at serine 51 in the α-helical region that
forms the two zinc fingers [38] and by protein kinase A
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the receptor’s VDRE-binding, RXR heterodimerization
and transactivation functions. Conversely, calcitriol-
stimulated, casein kinase II-catalyzed phosphorylation of
human VDR at serine 208 [39-41] does not affect the
receptor’s kinetics for hormone binding, its partitioning
into the nucleus or its ability to associate with DNA but
instead modulates its affinity for the 220 MW DRIP205/
TRAP220 subunit of the large DRIP (VDR interacting
proteins) mediator complex that directly anchors
liganded VDR to components of the RNA polymerase II
holoenzyme and hence amplifies its ability to transacti-
vate target promoters. In addition, activated calcium/
calmodulin-dependent kinase CaMKIV, which exhibits
30% identity and 45% similarity to PIM-1 (www.biobase.
international.com), dramatically stimulates calcitriol-
activated reporter gene expression by increasing VDR
phosphorylation levels and results in enhanced inter-
action between VDR and SRC coactivator proteins in
mammalian two-hybrid studies [42]. Calcitriol also acti-
vates mitogen-activated protein (MAPK) kinases in nor-
mal human keratinocytes [43] and other cell types [44],
thereby providing a rapid mechanism for the hormone to
promote its own receptor-mediated action and suggest-
ing a possible connection between the well-established
gene regulatory mechanisms mediated through the VDR
and the rapid response cascades. Functional studies on
other steroid hormone and retinoid receptors have simi-
larly implicated phosphorylation in the regulation of
DNA association [45], hormone binding [46], nuclear
localization [47] and transcriptional activation [48,49].
Similar modifications have also been reported for a var-
iety of NHR coregulators, including SRC-1, TIF2, RAC3,
p300, CBP, NcoR and SMRT [50,51], which may either
enhance their interaction with NHRs as well as their abil-
itiy to recruit histone acetyltransferase (HAT) complexes
(in the case of coactivators) or induce the redistribution
of corepressor from the nucleus to the cytoplasm,
thereby lessening the potential association between core-
pressors and NHRs [52-54].
Our domain mapping approaches have nevertheless
indicated that the interaction with PIM-1 kinase does
not involve the ligand-binding domain of VDR in con-
trary to the majority of co-activators. The interaction be-
tween PIM-1 and VDR is instead restricted to the
receptor’s DNA binding domain, a type of interaction
that, to our knowledge, has been described only 3 times
previously: (i) between VDR and the bone-specific tran-
scription factor Runx2 as a prerequisite to upregulate rat
osteocalcin expression in osteoblasts [55]; (ii) between
VDR and acute promyelocytic leukemia zinc finger pro-
tein (PLZF) necessary for the regulation of calcitriol-
induced monocytic differentiation in hematopoietic cells
[56]; and (iii), in a different experimental context,between VDR and the oncogenic nucleoporin CAN/
Nup214, a component of the nuclear pore complex [57].
Because yeast two-hybrid experiments do not allow
any conclusions about protein-protein interactions in a
native cellular environment, we also studied PIM-1 and
VDR in the spontaneously immortalized human HaCaT
cell line which is known to behave phenotypically like
normal basal epidermal keratinocytes in terms of growth
and differentiation and to develop in the absence of
serum and supplementary exogenous growth factors,
features which make it a widely used cell culture system
for such studies and an important model for the highly
proliferative epidermis [58]. As visualized by overexpres-
sing YFP-VDR and tomato-tagged PIM-1, we could ob-
serve significant co-localization of the two proteins in
the nucleus of HaCaT keratinocytes, which confirms that
both proteins could indeed have the opportunity to
interact with each other at the physiological level. We
were subsequently able to increase transcription of
CYP24A1 and osteopontin mRNA, the latter a classic
VDR response gene [59,60], by approximately 50% upon
extrachromosomal overexpression of PIM-1 kinase. Fur-
thermore, we similarly observed a clear enhancement of
extrachromosomal DR3 reporter response upon PIM-1
overespression and respectively a clear reduction in DR3
reporter response by PIM-1 shRNA mediated knock-
down, suggesting that PIM-1 kinase indeed can modu-
late calcitriol signaling. In an earlier study, Thompson
et al. [61] analyzed whether PIM-1 was capable of
modulating androgen signaling because androgens are
known to play a key role in male physiology as well as in
the promotion or progression of prostate cancer and
PIM-1 kinase was reported to be markedly overex-
pressed under such conditions [34]. Ruling out simple
explanations like altered receptor levels or DNA binding
characteristics, they observed that, under transient trans-
fection conditions, PIM-1 attenuated the transcriptional
activity of AR, another NHR superfamily member (and
in parallel experiments also of a LBD-deleted AR, GR
and ERα), in a dose-dependent fashion in several cell
types, but found no evidence for direct phosphorylation
of AR by PIM-1 or, in contrast to our results, for a direct
protein-protein interaction [61]. They therefore sug-
gested that PIM-1 likely influences AR activity via an in-
direct mechanism that possibly involves phosphorylation
of a coregulator and/or a component of the transcrip-
tional machinery. We could show that PIM-1 binds to
the DNA-binding domain of VDR and modulates calci-
triol signaling, however, we did not analyse the phos-
phorylation of VDR by PIM-1. Therefore it remains
unclear whether VDR or a different component of the
pathway is modulated by PIM-1. Interestingly, and in
this context it was reported that PIM-1 enhances the
transcriptional activity of c-myb, another transcription
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main as well as the phosphorylation of the transcrip-
tional co-activator p100 [24,62].
In a final pull-down of VDR-interacting protein com-
plexes we investigated the protein complex of VDR by
using the facility of a LXXLL containing peptide (DRIP-
2) to capture the VDR-interacting co-activator protein
complex in cell lysates. We detected the PIM-1 isoform
2 in the eluted fraction containing also VDR, but there
is no detection of endogene PIM-1 in the fraction with-
out DRIP-2 capture, so PIM-1 indeed seems to be
included into the VDR-complex captured by DRIP-2
peptide, and potentially a member of the DRIP205-VDR
co-activator complex [19].
Conclusion
Because the interaction between PIM-1 kinase and VDR
involves the DNA-binding domain of the latter, it is con-
ceivable that this association supports the binding of
VDR to VDRE response elements within specific target
genes, a hypothesis that will be tested in forthcoming




To construct the bait, the 1284 bp sequence encoding
full-length human vitamin D receptor (NCBI accession
no. NM_000376) was cloned by recombinational cloning
into pDONR/Zeo (Invitrogen, Carlsbad, CA, USA),
shuttled into the GAL4 DNA-binding domain (BD)-con-
taining vector pBD-Gate2 [11], and sequenced by using
an ABIPRISMTM Cycle Sequencing Kit and an ABI-
PRISMTM 310 Genetic Analyzer (Applied Biosystems,
Foster City, CA, USA). In a preliminary experiment, in
which the known interaction between p53 and SV40
large T antigen [63] served as positive control, the con-
struct was found to have no capacity to nonspecifically
activate reporter genes. A commercially available human
bone marrow cDNA library in the Gateway-compatible
pCMV-SPORT6 vector (Invitrogen) was transferred via
recombinational cloning into the GAL4 activation do-
main (AD) containing vectors pAD-Gate1, -Gate2, and
-Gate3 [11] vectors and purified by using a GenElute
HP Plasmid Maxiprep kit (Sigma-Aldrich, Taufkirchen,
Germany), resulting in three libraries that differ from
each other only in the translational reading frame. To
perform a large-scale Y2H screening with the MATCH-
MAKER GAL4 Two-hybrid System 3 (Clontech, Moun-
tain View, CA, USA), the VDR-pBD-Gate2 bait and each
of the 3 libraries were simultaneously co-transformed
into the haploid Saccharomyces cerevisiae strain AH109
(genotype: MATa, trp1-901, leu2-3, 112, ura3-52, his3-
200, gal4Δ, gal80Δ, LYS2:: GAL1UASGAL1TATA-HIS3,GAL2UAS-GAL2TATAADE2;URA3::MEL1UAS-MEL1TATA-
lacZ MEL1) according to a standard high-efficiency lith-
ium acetate method, and finally plated onto (i) a nutri-
tionally selective plate deficient in tryptophan and
leucine (SD/-leu-trp) to test for positive plasmid uptake
and general transformation efficiency, and (ii) SD/-trp-
leu-ade-his synthetic medium to select for actual re-
porter activity. The plates were incubated for at least
4 days at 28 °C. The cDNA library vectors from primary
positive yeast candidate clones were recovered by plas-
mid isolation via digestion with 10 U lyticase (Sigma-
Aldrich), addition of 10% SDS, one freeze-thaw cycle,
and purification by using a WizardW SV gel and PCR
clean-up system (Promega, Madison, WI, USA). The
plasmids were then amplified in E. coli DH5α cells and
reintroduced back into the yeast strain AH109 together
with the bait or empty pBD-Gate2 (as a control) and fi-
nally retested on SD/-trp-leu-ade-his in order to verify
their reporter activity before the sequence of the clone
was determined by using vector-specific primers. Bioin-
formatical analyses were conducted through the Na-
tional Center for Biotechnology Information (NCBI) by
using the basic local alignment search tool (BLAST) ac-
cessible via http://blast.ncbi.nlm.nih.gov/Blast.cgi, the
ExPASy Proteomics Server (http://www.expasy.ch/), the
Universal Protein Resource UniProt (www.uniprot.org/)
and the SWISS-PROT knowledgebase (http://expasy.
org/sprot/). Only putative VDR-interacting candidates
passing the control experiments were subjected to fur-
ther study.
Mapping the interacting domains
Full-length human PIM-1 kinase isoform 2 subcloned
into pDONR/zeo was shuttled into the pAD-Gate2 vec-
tor via an LR reaction and used as the prey plasmid in
our subsequent domain mapping experiments. The
ligand-binding domain (LBD, amino acids 111–427) and
the DNA-binding domain (DBD, AA 16–125) of human
VDR were similarly cloned into pDONR/Zeo and subse-
quently shuttled into pBD-Gate2, resulting in bait pro-
teins fused to the GAL4 DNA-binding domain. To
identify the protein regions involved in the interaction
between PIM-1 kinase and VDR, the particular bait and
prey vectors (or the respective empty vectors as negative
controls) were co-transformed into the haploid yeast
strain AH109 as described above. Positive interactions
were indicated by cell growth on SD/-leu-trp-ade-his
medium after 4 days of incubation at 28 C. Because dir-
ect plating of transformants onto SD/-leu-trp-ade-his
medium represents a rather stringent condition that
selects for only strong interactors, and hence could fail
to detect low-affinity, auto-activating, and perhaps tran-
sient interactions, we also tested a less stringent condi-
tion, i.e. we picked several random clones from SD/-leu-
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them onto SD/-leu-trp-ade-his [11].
Cell culture techniques and transfection
Cell culture experiments were performed with the spon-
taneously immortalized human keratinocyte cell line
HaCaT that was maintained as a monolayer culture
under a 5% CO2 at 37 C in Epilife
W medium (Cascade
Biologics/Invitrogen GmbH, Karlsruhe, Germany) to-
gether with defined human keratinocyte growth supple-
ment (HKGS), 60 μM CaCl2, and 0.5% penicillin/
streptomycin. For transfection experiments, 1-3×105
HaCaT cells were seeded in flasks or chamber slides that
allow cell cultivation in a microscopic carrier (BD Bios-
ciences, Erembodegem, Belgium, NuncTM/Lab-TEKW,
Langenselbold, Germany) to reach approximately 50% to
80% confluence, and electroporated by using a Cell line
NucleofectorW kit V (Amaxa Biosystems, Lonza GmbH,
Wuppertal, Germany) according to the manufacturer’s
instructions with a total of 5 μg plasmid DNA.
Co-localization studies
Human VDR subcloned into pDONR/Zeo [11] was
shuttled into pcDNATM6.2/N-EmGFP/YFP-DEST (Invi-
trogen) via a standard LR reaction to create an N- ter-
minally yellow fluorescent protein (YFP)-tagged protein.
Human PIM-1 was shuttled from the entry vector into
a GatewayW-compatible mammalian red fluorescent
pDEST/Tomato destination plasmid which we con-
structed through insertion of a tomato dimer sequence
amplified from pRSET-B tdTomato (Invitrogen) into
pcDNATM3.1D/V5-His-TOPO (Invitrogen). To investi-
gate the actual co-localization between PIM-1 and VDR,
exponentially grown HaCaT cells transfected with a
combination of YFP-VDR and Tomato-PIM-1 were cul-
tured onto chamber slides as described above, rinsed
with 1x PBS, fixed in 4% paraformaldehyde in 1x PBS
for 10 min and counterstained with 1 μg/ml 1,4,6-dia-
midino-2-phenylindole (DAPI). After three additional
washing steps, the coverslips were inverted into mount-
ing medium (MicroTrakW, Trinity Biotech PLC,Table 1 Primer sequences for the Real-Time PCR Analysis
gene name Abbreviation Acc No
Annexin ANXA1 NM_000700 forwa
rever
Cyp24A1 CYP24 NM_000782 forwa
rever
Osteopontin ON NM_000582 forwa
rever
PIM-1 kinase PIM1 NM_002648 forwa
reverWicklow, Ireland) and the fluorescence staining was
evaluated with a Zeiss Axioskop MC100 (Carl Zeiss
MicroImaging GmbH, Göttingen, Germany).
Real-time PCR analysis
Total RNA from HaCaT keratinocytes grown to approxi-
mately 90% confluence was isolated with an RNeasy
Midi Kit (Qiagen GmbH, Hilden, Germany) according to
the kit’s manual. RNA purity and concentration were
analysed using a NanodropW ND-1000 UV/Vis Spectro-
photometer (PEQLAB GmbH, Erlangen, Germany) and
RNA integrity visually assessed by agarose gel electro-
phoresis. After a 20-min digest with DNase I (Sigma-
Aldrich) at 25 C to remove DNA contamination, 0.55 μg
of purified RNA was reverse transcribed into cDNA with
an iScript™ cDNA Synthesis Kit (Bio-Rad Laboratories,
Hercules, CA, USA) by incubating the reaction for
5 min at 25 C, for 30 min at 42 C, and for an additional
5 min at 85 C in a programmable thermocycler. The
resulting cDNA (or an equal amount of DNase-digested
RNA for a negative control) was used as a template for
quantitative real-time PCR using an iQ™ SYBR green
Supermix, an iCycler™ apparatus (both Bio-Rad Labora-
tories) and the following conditions: a hot-start incuba-
tion at 95 C for 5 min and 50 cycles consisting of
denaturation at 95 C for 30 s, primer annealing at 60 C
for 20 s, and elongation at 72 C for 20 s, followed by 50
cycles of fluorescence acquisition that determines the
specifity of the amplified products and verifies the ab-
sence of oligonucleotide-dimer formation. All PCRs were
carried out in a final total volume of 25 μl and were per-
formed in triplicates for each cDNA sample. The real-
time primers used in this study were designed by using
Primer3 software available at http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi. A complete list of oligo-
nucleotides is given in Table 1. The obtained data were
normalized against annexin A1, an unregulated en-
dogenous reference transcript, as control for any analytic
variation. Results were analyzed with the iCycler iQ™ op-
tical system software 3.1 (Bio-Rad Laboratories,
Hercules, CA, USA) by comparing the distinct cycleSequence Product size
rd 5´- GCAGGCCTGGTTTATTGAAA −3´ 203 bp
se 5´- GCTGTGCATTGTTTCGCTTA −3´
rd 5´- GGCAACAGTTCTGGGTGAAT −3´ 249 bp
se 5´- TATTTGCGGACAATCCAACA −3´
rd 5´- TGAAACGAGTCAGCTGGATG −3´ 162 bp
se 5´- TGAAATTCATGGCTGTGGAA −3´
rd 5´- CAGAGTGGATCCGCTACCAT −3´ 226 bp
se 5´- TGGATTTCTTCGAAGGTTGG −3´
Table 2 PIM-1-specific shRNA sequences for
PIM-1-knockdown
construct 29mer Sequence
GI362006 TGG AAG TGG TCC TGC TGA AGA AGG TGA GC
GI362007 CTG CTC AAG GAC ACC GTC TAC ACG GAC TT
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lyzed samples compared to their controls were shown as
fold change and respective p-values were calculated
using a homoscedastic t-test (only data with p-value< 0
.05 were considered statistically significant).GI362008 CCT GAG ACC ATC AGA TAG GCC AAC CTT CG
GI362009 CAG AAT GTC AGC ATC TCA TTA GAT GGT GCReporter assay measurements and PIM-1 knockdown
PIM-1 kinase was shuttled via an LR reaction into the
mammalian destination vector pDEST26 (Invitrogen)
and transfected into HaCaT cells together with a VDRE-
luc reporter (Cignal Vitamin D Reporter Kit, CCS-
2029 L, SABiosciences Corporation, Frederick, MD,
USA), which gives reproducible, sensitive and specific
measurements of changes in transcriptional activities.
The VDRE-luc reporter is a mixture of (i) an inducible
firefly (Photinus pyralis) luciferase reporter gene under
control of a basal TATA box control element joined to
tandem repeats of a specific transcriptional response
element, and (ii) a constitutively expressed Renilla
(Renilla reniformis) luciferase regulated by a CMV im-
mediate early enhancer/promoter that can be used as an
internal reference for standardizing experimental vari-
abilities such as transfection efficiencies and cell viabil-
ity. As a negative control, empty pDEST26 was co-
transfected with VDRE-luc in a parallel approach. Trans-
fected samples were split into a CorningW CellBINDW
Surface plate (Corning Life Sciences, Lowell, MA, USA)
and incubated for 48 h at 37 C before the samples were
treated with 0.2 μM calcitriol or an equal amount of
ethanol as vehicle for further 16 h. The cells were then
gently and rapidly lysed with passive lysis buffer (pro-
vided with the kit), which is formulated to circumvent
the need for scraping of adherent cells or additional
freeze-thaw cycles. The assay was developed by measur-
ing the activities of firefly and Renilla luciferase reporters
sequentially from each sample by using a Dual-
LuciferaseW Reporter (DLR™) System (Promega). Pro-
moter activity values were expressed as arbitrary units
after normalization and correction for background re-
activity. The PARADIGM™ Detection Platform (Beck-
man CoulterW Inc., Fullerton, CA, USA) was used for
signal detection.
For PIM-1 knockdown PIM-1 specific short hairpin
RNA (shRNA) encoding plasmid constructs in pGFP-V-
RS was obtained from Origene (HuSH™-29; Origene,
Rockville, MD, USA). The set of four 29mer shRNA
constructs (Table 2) were co-transfected with VDRE-luc
reporters into HaCaT cells. As negative control the
empty shRNA pGFP-V-RS vector (Origene) was used
with VDRE-luc. The assays were induced by calcitriol or
an equal amount of ethanol and measured in the same
way. All data between calcitriol treated and control cells
were calculated to be statistically significant using ahomoscedastic t-test (only data with p-value< 0.05 were
considered statistically significant).Isolation of VDR-protein complex from human
keratinocyte cell lysate
HaCaT keratinocytes grown to approximately 90% con-
fluence were lysed using RIPA-buffer (Sigma-Aldrich,
Taufkirchen, Germany). The flasks were washed twice
with 10 ml cold PBS, incubated in 750 μl RIPA-buffer
with protease inhibitor cocktail for 10 min at 25 °C fol-
lowed by 10 min incubation at −80 °C. Cells were col-
lected with a cell scrapper, and quantified using a
classical Bradford assay.
6 mg of the lysates were pre-incubated with 50 μl
magnetic Streptavidin beads (DynabeadsWMyOne™Strep-
tavidin T1 Invitrogen) for 10 min. The beads were cap-
tured and the lysates were incubated without and with
1 μg of a synthetic biotinylated DRIP-2 peptide (Genway
Biotech.Inc, San Diego, CA, USA) overnight at 4 °C with
gentle agitation. The DRIP-2 peptide is an LXXLL motif
containing peptide (N – NTKNHPMLMNLLKDNPAQD
– C) with the facility to bind the VDR [19].
After overnight incubation 100 μl magnetic streptavi-
din beads were added to the lysates and incubated for
1.5 h at 25 °C. The beads were washed 4 times each
10 min with TBS + 0.05%TWEEN and then captured by
a magnetic stand. The beads were resolved with 30 μl
LDS-loading buffer and incubated for 5 min at 96 °C to
elute the complex. 5 μl of each eluted protein peptide
complexes were further analyzed by standard western
blot procedures. The primary antibodies were the com-
mercially available rabbit polyclonal IgG anti-human
VDR antibody (sc-1008; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) for the VDR and the commercial
available rabbit polyclonal IgG anti-human PIM-1 anti-
body (sc-28777; Santa Cruz Biotechnology) for PIM-1.
For detection, an HRP conjugated swine anti-rabbit
polyclonal IgG antibody (P0217; Dako, Glostrub, Den-
mark) was used.
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